Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.18B |
| 2 |
Medtronic
MDT
|
+$2.06B |
| 3 |
Microsoft
MSFT
|
+$1.61B |
| 4 |
Procter & Gamble
PG
|
+$1.47B |
| 5 |
UBS Group
UBS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.42B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.34B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$930M |
| 4 |
Apple
AAPL
|
+$637M |
| 5 |
SWY
SAFEWAY INC
SWY
|
+$620M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.67% |
| 2 | Technology | 13.6% |
| 3 | Financials | 13.57% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LDRH
2301
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $21M | ﹤0.01% |
572,421
+144,652
| +34% | +$5.25M |
|
2302
Myers Industries
MYE
$1.29B
| $20.8M | ﹤0.01% |
1,188,624
+77,014
| +7% | +$1.36M |
|
2303
AngioDynamics
ANGO
$649M
| $20.8M | ﹤0.01% |
1,171,249
+78,460
| +7% | +$1.46M |
|
2304
Companhia Siderúrgica Nacional
SID
$1.23B
| $20.8M | ﹤0.01% |
12,743,676
-91,818
| -0.7% | -$163K |
|
|
EXXI
2305
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $20.8M | ﹤0.01% |
5,706,370
+153,065
| +3% | +$535K |
|
|
OB
2306
DELISTED
Onebeacon Insurance Group Ltd
OB
| $20.7M | ﹤0.01% |
1,362,849
+48,678
| +4% | +$760K |
|
|
EVRI
2307
DELISTED
Everi Holdings
EVRI
| $20.7M | ﹤0.01% |
2,719,693
+127,859
| +5% | +$911K |
|
2308
WSFS Financial
WSFS
$4.15B
| $20.7M | ﹤0.01% |
821,595
+47,589
| +6% | +$1.21M |
|
|
NVRO
2309
DELISTED
NEVRO CORP.
NVRO
| $20.7M | ﹤0.01% |
432,135
+80,683
| +23% | +$3.5M |
|
|
STFC
2310
DELISTED
State Auto Financial Corp
STFC
| $20.7M | ﹤0.01% |
852,115
+28,994
| +4% | +$663K |
|
|
HSII
2311
DELISTED
Heidrick & Struggles
HSII
| $20.6M | ﹤0.01% |
836,918
+45,730
| +6% | +$1.07M |
|
2312
Cavco Industries
CVCO
$4.55B
| $20.5M | ﹤0.01% |
273,230
+20,192
| +8% | +$1.49M |
|
2313
US Physical Therapy
USPH
$1.22B
| $20.4M | ﹤0.01% |
430,293
+20,197
| +5% | +$859K |
|
2314
Vanguard Total International Bond ETF
BNDX
$82.2B
| $20.4M | ﹤0.01% |
377,488
+206,280
| +120% | +$11.1M |
|
2315
Community Trust Bancorp
CTBI
$1.41B
| $20.4M | ﹤0.01% |
614,289
-100,235
| -14% | -$3.31M |
|
|
FBR
2316
DELISTED
Fibria Celulose Sa
FBR
| $20.4M | ﹤0.01% |
1,483,009
+25,441
| +2% | +$318K |
|
|
EXAR
2317
DELISTED
Exar Corporation
EXAR
| $20.4M | ﹤0.01% |
2,025,031
+100,001
| +5% | +$1.02M |
|
|
PGTI
2318
DELISTED
PGT, Inc.
PGTI
| $20.1M | ﹤0.01% |
1,802,823
+171,977
| +11% | +$1.67M |
|
|
BNFT
2319
DELISTED
Benefitfocus, Inc.
BNFT
| $20.1M | ﹤0.01% |
545,466
+33,625
| +7% | +$1.01M |
|
2320
El Pollo Loco
LOCO
$462M
| $20M | ﹤0.01% |
781,911
+58,642
| +8% | +$1.46M |
|
2321
Marten Transport
MRTN
$1.22B
| $19.9M | ﹤0.01% |
2,140,633
+131,660
| +7% | +$1.16M |
|
|
ACAT
2322
DELISTED
Arctic Cat Inc
ACAT
| $19.8M | ﹤0.01% |
546,219
+29,937
| +6% | +$1.08M |
|
2323
Geron
GERN
$949M
| $19.8M | ﹤0.01% |
5,250,900
+192,343
| +4% | +$653K |
|
2324
RB Global
RBA
$17.5B
| $19.8M | ﹤0.01% |
+793,374
| New | +$20.2M |
|
|
IO
2325
DELISTED
ION Geophysical Corporation
IO
| $19.8M | ﹤0.01% |
607,585
+41,464
| +7% | +$1.49M |
|
Similar funds
Vanguard Group's Q1 2015 Portfolio in Review
As of Q1 2015, Vanguard Group held 4,228 positions worth $1.47T, up 6.2% from $1.39T the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Vanguard Group deployed $66B of net new capital in Q1 2015, opening 181 new positions and adding to 3,456 existing holdings. Its largest new stake was UBS Group: 57,940,325 shares worth $1.09B.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $637M trimmed.
- Vanguard Group's largest Q1 2015 buy was UBS Group: 57,940,325 shares worth $1.09B.
- Vanguard Group added most to Allergan plc in Q1 2015, an estimated $2.18B increase.
- Vanguard Group's biggest Q1 2015 reduction was Apple, cutting an estimated $637M.
- Vanguard Group fully exited Allergan Inc in Q1 2015, selling an estimated $3.42B.
- Vanguard Group's ten largest holdings make up 12% of its $1.47T portfolio in Q1 2015.
- Vanguard Group opened 181 new positions and closed 75 in Q1 2015.
- Vanguard Group's portfolio value rose 6.2% quarter-over-quarter to $1.47T.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.